OF
ETNB

Optimize Financial’s 89bio ETNB Stock Holding History

Optimize Financial’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-47,871
Closed -$704K – 321
2025
Q3 		$704K Buy
47,871
+27,883
+139% +$284K 0.37% 54
2025
Q2 		$196K Sell
19,988
-142
-0.7% -$1.18K 0.12% 214
2025
Q1 		$146K Sell
20,130
-5,666
-22% -$49.5K 0.11% 209
2024
Q4 		$202K Buy
+25,796
New +$212K 0.15% 215

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Optimize Financial's ETNB Position: Q4 2025 in Review

Optimize Financial sold out of 89bio (ETNB) in Q4 2025, closing a stake of 47,871 shares — an estimated $704K sold.

Optimize Financial first reported a position in ETNB in Q4 2024 and held it in 4 quarters. The position peaked at $704K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Optimize Financial reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Optimize Financial sold 47,871 89bio shares in Q4 2025, an estimated $704K.
  • Optimize Financial first reported a position in 89bio in Q4 2024 and held it in 4 quarters.
  • Optimize Financial's 89bio position peaked at $704K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Optimize Financial's 13F filing for Q4 2025, filed 9 Feb 2026.